May 2017 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2017. This roundup includes the latest...
Intra-Arterial Treatment Effective With Extracranial Carotid Disease
IAT seems to be at least as effective for patients with acute ischemic stroke, with versus without ECD
Risk of Conversion to Multiple Sclerosis Down With Minocycline
Treatment with minocycline reduces conversion to MS over six months after first demyelinating event
Excess Weight Increases Costs Across Health Care Settings
Percentage increases in costs associated with obesity were highest for medications, higher for women
Brain Changes in MS May Contribute to Lack of Empathy
Diffuse normal-appearing white matter damage may create disconnection in social brain network
Evacetrapib Appears Futile in High-Risk Vascular Disease
No reduction in primary end point events, including death from cardiovascular causes, MI, stroke
High-Risk Pools May Represent Step Back for U.S. Health Care
Higher premiums, deductibles, out-of-pocket costs likely to make high-risk pools unaffordable
Sleeping Sickness Medication May Help Lessen ASD Symptoms
Small study produced positive results with suramin, but more research needed
Social Psychology May Help With Physician Error Disclosure
Deliberate practice, together with lessons from social psychology, can implement change in error disclosure
Targeting ANGPTL3 Can Significantly Lower Cholesterol
Two trials show promise for non-statin approach to cardiovascular disease prevention
